Literature DB >> 23624999

Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010.

Sara Karami1, Sarah E Daugherty, Sara J Schonfeld, Yikyung Park, Albert R Hollenbeck, Robert L Grubb, Jonathan N Hofmann, Wong-Ho Chow, Mark P Purdue.   

Abstract

Clinical and experimental findings suggest that female hormonal and reproductive factors could influence kidney cancer development. To evaluate this association, we conducted analyses in 2 large prospective cohorts (the National Institutes of Health-AARP Diet and Health Study (NIH-AARP), 1995-2006, and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO), 1993-2010). Cohort-specific and aggregated hazard ratios and 95% confidence intervals relating reproductive factors and kidney cancer risk were computed by Cox regression. The analysis included 792 incident kidney cancer cases among 283,952 postmenopausal women. Women who had undergone a hysterectomy were at a significantly elevated kidney cancer risk in both NIH-AARP (hazard ratio = 1.28, 95% confidence interval: 1.09, 1.50) and PLCO (hazard ratio = 1.41, 95% confidence interval: 1.06, 1.88). Similar results were observed for both cohorts after analyses were restricted to women who had undergone a hysterectomy with or without an oophorectomy. For the NIH-AARP cohort, an inverse association was observed with increasing age at menarche (P for trend = 0.02) and increasing years of oral contraceptive use (P for trend = 0.02). No clear evidence of an association with parity or other reproductive factors was found. Our results suggest that hysterectomy is associated with increased risk of kidney cancer. The observed associations with age at menarche and oral contraceptive use warrant further investigation.

Entities:  

Keywords:  hysterectomy; kidney cancer; parity; pooled analysis; reproductive factors

Mesh:

Substances:

Year:  2013        PMID: 23624999      PMCID: PMC3676151          DOI: 10.1093/aje/kws406

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  46 in total

1.  Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.

Authors:  A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

2.  Human renal cell carcinoma as a hormone-dependent tumor.

Authors:  G Concolino; A Marocchi; C Conti; R Tenaglia; F Di Silverio; U Bracci
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

3.  Increased risk of renal cell carcinoma subsequent to hysterectomy.

Authors:  M Gago-Dominguez; J E Castelao; J M Yuan; R K Ross; M C Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-11       Impact factor: 4.254

4.  Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors.

Authors:  E L Cavalieri; S Kumar; R Todorovic; S Higginbotham; A F Badawi; E G Rogan
Journal:  Chem Res Toxicol       Date:  2001-08       Impact factor: 3.739

5.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors:  P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

6.  Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study.

Authors:  Janet E Olson; James R Cerhan; Carol A Janney; Kristin E Anderson; Celine M Vachon; Thomas A Sellers
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

7.  Steroid hormone receptors in normal and malignant human renal tissue: relationship with progestin therapy.

Authors:  E Ronchi; G Pizzocaro; P Miodini; L Piva; R Salvioni; G Di Fronzo
Journal:  J Steroid Biochem       Date:  1984-09       Impact factor: 4.292

Review 8.  Reproductive endocrinologic alterations in female asymptomatic obesity.

Authors:  R Azziz
Journal:  Fertil Steril       Date:  1989-11       Impact factor: 7.329

9.  Oestrogen-induced renal carcinoma.

Authors:  I Nissenkorn; C Servadio; I Avidor
Journal:  Br J Urol       Date:  1979-02

10.  Pregnancy and risk of renal cell cancer: a population-based study in Sweden.

Authors:  Mats Lambe; P Lindblad; J Wuu; R Remler; C-c Hsieh
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

View more
  13 in total

1.  Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.

Authors:  Katie S Murray; Emily C Zabor; Massimiliano Spaliviero; Paul Russo; Wassim M Bazzi; John E Musser; A Ari Hakimi; Melanie L Bernstein; Guido Dalbagni; Jonathan A Coleman; Helena Furberg
Journal:  World J Urol       Date:  2016-04-22       Impact factor: 4.226

2.  Oral contraceptive use and kidney cancer risk among women: evidence from a meta-analysis.

Authors:  Huan Liu; Xing-Chun Wang; Guang-Hui Hu; Tian-Bao Huang; Yun-Fei Xu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study.

Authors:  Kara A Michels; Louise A Brinton; Ruth M Pfeiffer; Britton Trabert
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

4.  Hysterectomy and kidney cancer risk: a meta-analysis.

Authors:  Sara Karami; Sarah E Daugherty; Mark P Purdue
Journal:  Int J Cancer       Date:  2013-07-30       Impact factor: 7.396

5.  Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort.

Authors:  Won Jin Ho; Michael S Simon; Vedat O Yildiz; James M Shikany; Ikuko Kato; Jennifer L Beebe-Dimmer; Jeremy P Cetnar; Cathryn H Bock
Journal:  Cancer       Date:  2014-10-09       Impact factor: 6.860

Review 6.  Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer.

Authors:  William V Williams; Louise A Mitchell; S Kathleen Carlson; Kathleen M Raviele
Journal:  Linacre Q       Date:  2019-01-03

7.  Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma.

Authors:  Mark P Purdue; Jongeun Rhee; Lee Moore; Xiaohua Gao; Xuezheng Sun; Erin Kirk; Vladimir Bencko; Vladimir Janout; Dana Mates; David Zaridze; Stacey Petruzella; Abraham Ari Hakimi; William Marston Linehan; Stephen J Chanock; Paul Brennan; Helena Furberg; Melissa Troester; Nathaniel Rothman
Journal:  Int J Cancer       Date:  2021-06-10       Impact factor: 7.316

8.  Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts.

Authors:  Barbara J Fuhrman; Steven C Moore; Celia Byrne; Issam Makhoul; Cari M Kitahara; Amy Berrington de González; Martha S Linet; Elisabete Weiderpass; Hans-Olov Adami; Neal D Freedman; Linda M Liao; Charles E Matthews; Rachael Z Stolzenberg-Solomon; Mia M Gaudet; Alpa V Patel; I-Min Lee; Julie E Buring; Alicja Wolk; Susanna C Larsson; Anna E Prizment; Kim Robien; Michael Spriggs; David P Check; Neil Murphy; Marc J Gunter; Harold L Van Dusen; Regina G Ziegler; Robert N Hoover
Journal:  Cancer Res       Date:  2021-04-05       Impact factor: 13.312

Review 9.  Review on renal cell carcinoma and pregnancy: A challenging situation.

Authors:  Hussein Khaled; Nasr Al Lahloubi; Noha Rashad
Journal:  J Adv Res       Date:  2016-03-31       Impact factor: 10.479

10.  Peculiarities and management challenges of advanced renal cell carcinoma incidentally discovered in pregnancy.

Authors:  Rotimi A David; Boluwatife Idowu; Cathlyn Akindiose; Adeyinka Laoye; John A Aluko; Adeleye D Omisore; Emmanuel Alajiki; Akinwumi O Komolafe; Abdulkadir A Salako; Uchenna Onwudiegwu
Journal:  Clin Case Rep       Date:  2018-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.